| Predicted Trait | |
| Reported Trait | Glioma |
| Mapped Trait(s) | glioma (EFO_0005543) |
| Score Construction | |
| PGS Name | PRS28_glioma |
| Development Method | |
| Name | Genome-wide significant variants |
| Parameters | r2>=0.93 |
| Variants | |
| Original Genome Build | hg19 |
| Number of Variants | 28 |
| Effect Weight Type | NR |
| PGS Source | |
| PGS Catalog Publication (PGP) ID | PGP000328 |
| Citation (link to publication) | Choi J et al. Int J Cancer (2020) |
| Ancestry Distribution | |
| Source of Variant Associations (GWAS) | European: 100% 30,659 individuals (100%) |
| PGS Evaluation | European: 100% 1 Sample Sets |
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
|---|---|---|---|
GWAS Catalog: GCST004347 Europe PMC: 28346443 |
30,659 individuals | European | 14 cohorts
|
|
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
|---|---|---|---|---|---|---|---|---|
| PPM013031 | PSS009663| European Ancestry| 312 individuals |
PGP000328 | Choi J et al. Int J Cancer (2020) |
Reported Trait: Glioma | — | AUROC: 0.61 [0.57, 0.64] | — | — | — |
| PPM013039 | PSS009663| European Ancestry| 312 individuals |
PGP000328 | Choi J et al. Int J Cancer (2020) |
Reported Trait: Glioma | — | — | Hazard ratio (HR top 5% vs average): 2.55 [1.72, 3.77] | Age, birth cohort, genotyping array, top 10 PCs for ancestry and sex (for nonsex specific cancer only) | — |
|
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
|---|---|---|---|---|---|---|---|---|
| PSS009663 | glioma (ICD-9 = 191 or ICD-10 = C71; ICD-O: 9380-9480) | — | 312 individuals | — | European | — | UKB | — |